MedTrace Logo

Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes

NCT01855412 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1204

Last updated 2023-07-18

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate acute and long term clinical and economic outcomes of endovascular procedures to treat Peripheral Arterial Disease (PAD).

Conditions

  • Peripheral Arterial Occlusive Disease

Interventions

OTHER

PAD endovascular treatments

All FDA-cleared endovascular PAD treatments

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • William Gray, MD · Columbia University

  • Gary Ansel, MD · Ohio Health

  • George Adams, MD · Rex Healthcare

  • Jihad Mustapha, MD · Advanced Cardiac & Vascular Centers

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2019-04-11
Completion
2019-04-11

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01855412 on ClinicalTrials.gov